|
US5914132A
(en)
*
|
1993-02-26 |
1999-06-22 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US5605889A
(en)
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
|
FI964452L
(fi)
*
|
1994-05-06 |
1996-11-05 |
Pfizer |
Atsitromysiinin kontrolloidun vapautumisen annostusmuotoja
|
|
US6262115B1
(en)
*
|
1995-05-22 |
2001-07-17 |
Alza Coporation |
Method for the management of incontinence
|
|
US5912268A
(en)
*
|
1995-05-22 |
1999-06-15 |
Alza Corporation |
Dosage form and method for treating incontinence
|
|
US6548084B2
(en)
|
1995-07-20 |
2003-04-15 |
Smithkline Beecham Plc |
Controlled release compositions
|
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
HRP970493A2
(en)
*
|
1996-09-23 |
1998-08-31 |
Wienman E. Phlips |
Oral delayed immediate release medical formulation and method for preparing the same
|
|
CA2271569C
(en)
*
|
1996-11-15 |
2003-01-28 |
Gary Lee Manring |
Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
|
|
US6551616B1
(en)
|
1997-04-11 |
2003-04-22 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US6010718A
(en)
*
|
1997-04-11 |
2000-01-04 |
Abbott Laboratories |
Extended release formulations of erythromycin derivatives
|
|
US20040028735A1
(en)
*
|
1997-11-14 |
2004-02-12 |
Unchalee Kositprapa |
Pharmaceutical formulation
|
|
US6306642B1
(en)
*
|
1997-11-24 |
2001-10-23 |
Quidel Corporation |
Enzyme substrate delivery and product registration in one step enzyme immunoassays
|
|
KR100440553B1
(ko)
*
|
1998-03-26 |
2004-07-15 |
후지사와 야꾸힝 고교 가부시키가이샤 |
서방성 제제
|
|
PT1083879E
(pt)
*
|
1998-06-03 |
2005-01-31 |
Alza Corp |
Metodos e dispositivos para proporcionar uma terapia de drogas prolongada
|
|
AU1238500A
(en)
*
|
1998-11-02 |
2000-05-22 |
Alza Corporation |
Controlled delivery of active agents
|
|
DE19850445A1
(de)
*
|
1998-11-02 |
2000-05-04 |
Falk Pharma Gmbh |
Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
|
|
US6706283B1
(en)
*
|
1999-02-10 |
2004-03-16 |
Pfizer Inc |
Controlled release by extrusion of solid amorphous dispersions of drugs
|
|
ATE404178T1
(de)
*
|
1999-02-10 |
2008-08-15 |
Pfizer Prod Inc |
Vorrichtung mit matrixgesteuerter wirkstofffreisetzung
|
|
US6878386B1
(en)
*
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
|
NZ517466A
(en)
|
1999-09-02 |
2003-11-28 |
Nostrum Pharmaceuticals Inc |
Controlled release oral dosage suitable for oral administration
|
|
ATE324868T1
(de)
*
|
1999-12-09 |
2006-06-15 |
Boots Co Plc |
Komprimierte zubereitung enthaltend nichtsteroidale entzündungshemmer
|
|
MXPA02006335A
(es)
|
1999-12-23 |
2002-12-13 |
Pfizer Prod Inc |
Forma de dosificacion de farmaco en capas impulsada por hidrogel.
|
|
JP4100910B2
(ja)
*
|
1999-12-23 |
2008-06-11 |
ファイザー・プロダクツ・インク |
ヒドロゲル駆動の薬物剤形
|
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
|
US6565882B2
(en)
|
2000-02-24 |
2003-05-20 |
Advancis Pharmaceutical Corp |
Antibiotic composition with inhibitor
|
|
US6544555B2
(en)
*
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
|
US6991807B2
(en)
*
|
2000-02-24 |
2006-01-31 |
Advancis Pharmaceutical, Corp. |
Antibiotic composition
|
|
IL135061A0
(en)
*
|
2000-03-14 |
2001-05-20 |
Ahron Jodaikin |
Strategic targeted fluoridation and chemical treatment of teeth
|
|
US20050175959A1
(en)
*
|
2000-03-14 |
2005-08-11 |
Coll Partners Ltd. |
System for the controlled delivery of an active material to a dental site
|
|
US6569152B2
(en)
|
2000-03-21 |
2003-05-27 |
Farrington Pharmaceuticals, Llc |
Sustained release delivery systems for solutes
|
|
FR2811571B1
(fr)
*
|
2000-07-11 |
2002-10-11 |
Flamel Tech Sa |
Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif
|
|
US20030086972A1
(en)
*
|
2000-08-09 |
2003-05-08 |
Appel Leah E. |
Hydrogel-driven drug dosage form
|
|
WO2002017918A2
(en)
|
2000-08-30 |
2002-03-07 |
Pfizer Products Inc. |
Sustained release formulations for growth hormone secretagogues
|
|
GB0025208D0
(en)
*
|
2000-10-13 |
2000-11-29 |
Euro Celtique Sa |
Delayed release pharmaceutical formulations
|
|
US6541014B2
(en)
*
|
2000-10-13 |
2003-04-01 |
Advancis Pharmaceutical Corp. |
Antiviral product, use and formulation thereof
|
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
|
US20020197314A1
(en)
|
2001-02-23 |
2002-12-26 |
Rudnic Edward M. |
Anti-fungal composition
|
|
FR2821745B1
(fr)
*
|
2001-03-09 |
2004-07-02 |
Ethypharm Lab Prod Ethiques |
Granules et granules enrobes au gout masque
|
|
CA2444569C
(en)
*
|
2001-04-18 |
2011-01-04 |
Nostrum Pharmaceuticals Inc. |
A novel coating for a sustained release pharmaceutical composition
|
|
HRP20010301A2
(en)
*
|
2001-04-27 |
2001-12-31 |
Pliva D D |
New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
|
|
SI1390377T1
(sl)
|
2001-05-22 |
2006-06-30 |
Pfizer Prod Inc |
Nova kristalna oblika azitromicina
|
|
US20080305173A1
(en)
*
|
2001-07-31 |
2008-12-11 |
Beuford Arlie Bogue |
Amorphous drug beads
|
|
AP1729A
(en)
*
|
2001-08-21 |
2007-03-26 |
Pfizer Prod Inc |
Single dose azithromycin for treating respiratory infections.
|
|
WO2003017981A1
(en)
*
|
2001-08-29 |
2003-03-06 |
Ranbaxy Laboratories Limited |
Controlled release formulation of clarithromycin or tinidazol
|
|
FR2830447B1
(fr)
*
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
|
US8101209B2
(en)
*
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
|
EP1541134A3
(en)
*
|
2001-10-18 |
2007-06-06 |
Teva Pharmaceutical Industries Limited |
Stabilized azithromycin compositions
|
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
|
US20030152622A1
(en)
*
|
2001-10-25 |
2003-08-14 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral diuretic
|
|
US20030091630A1
(en)
*
|
2001-10-25 |
2003-05-15 |
Jenny Louie-Helm |
Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
|
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
|
US7612112B2
(en)
*
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
|
WO2003053428A1
(en)
*
|
2001-12-20 |
2003-07-03 |
Pharmacia Corporation |
Controlled release dosage form having improved drug release properties
|
|
CN1668282A
(zh)
*
|
2001-12-21 |
2005-09-14 |
辉瑞产品公司 |
可直接压制的阿齐霉素配方
|
|
PL371125A1
(en)
*
|
2001-12-21 |
2005-06-13 |
Pfizer Products Inc. |
Methods for wet granulating azithromycin
|
|
RU2212242C1
(ru)
*
|
2001-12-24 |
2003-09-20 |
Закрытое акционерное общество "Брынцалов-А" |
Антибиотик сумазид
|
|
MXPA04007433A
(es)
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Procedimiento para preparar dispersiones solidas amorfas homogeneas de farmaco secadas por pulverizacion utilizando un dispositivo de secado por pulverizacion modificado.
|
|
WO2003063838A1
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Dry granulated formulations of azithromycin
|
|
US6682759B2
(en)
*
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
|
MXPA04007435A
(es)
*
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Metodo para preparar dispersiones solidas amorfas de farmacos secadas por pulverizacion utilizando inyectores a presion.
|
|
KR100540035B1
(ko)
*
|
2002-02-01 |
2005-12-29 |
주식회사 태평양 |
다단계 경구 약물 방출 제어 시스템
|
|
GB0203296D0
(en)
*
|
2002-02-12 |
2002-03-27 |
Glaxo Group Ltd |
Novel composition
|
|
IL164221A0
(en)
*
|
2002-04-09 |
2005-12-18 |
Flamel Tech Sa |
Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
|
|
US7906145B2
(en)
|
2002-04-09 |
2011-03-15 |
Flamel Technologies |
Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)
|
|
RU2283116C2
(ru)
*
|
2002-05-27 |
2006-09-10 |
Курский государственный медицинский университет |
Способ увеличения выживаемости изолированного кожного лоскута "на ножке" у животных с пониженным антиоксидантным фоном
|
|
WO2003105810A1
(en)
*
|
2002-06-14 |
2003-12-24 |
Andrx Corporation |
Pharmaceutical compositions for drugs having ph-dependentsolubility
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
GB0214013D0
(en)
*
|
2002-06-18 |
2002-07-31 |
Euro Celtique Sa |
Pharmaceutical product
|
|
US20040028737A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
|
US8980870B2
(en)
*
|
2002-09-24 |
2015-03-17 |
Boehringer Ingelheim International Gmbh |
Solid telmisartan pharmaceutical formulations
|
|
US20040062778A1
(en)
*
|
2002-09-26 |
2004-04-01 |
Adi Shefer |
Surface dissolution and/or bulk erosion controlled release compositions and devices
|
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
|
AU2003284942A1
(en)
*
|
2002-10-30 |
2004-06-07 |
Pharmacia Corporation |
Oral extended release tablets and methods of making and using the same
|
|
US7351430B2
(en)
*
|
2002-11-06 |
2008-04-01 |
Uluru Inc. |
Shape-retentive hydrogel particle aggregates and their uses
|
|
US7811605B2
(en)
*
|
2002-11-06 |
2010-10-12 |
Uluru Inc. |
Method of formation of shape-retentive aggregates of gel particles and their uses
|
|
US7670627B2
(en)
*
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
|
US20040114368A1
(en)
*
|
2002-12-13 |
2004-06-17 |
Shyu Shing Jy |
Light device having rotatable or movable view
|
|
JP4633469B2
(ja)
|
2002-12-16 |
2011-02-16 |
キッセイ薬品工業株式会社 |
経口固形医薬
|
|
US7910128B2
(en)
*
|
2003-01-03 |
2011-03-22 |
Supernus Pharmaceuticals, Inc. |
Use of a mixture of two or more enteric materials to regulate drug release via membrane or matrix for systemic therapeutics
|
|
FR2850577B1
(fr)
*
|
2003-02-03 |
2005-04-15 |
Ethypharm Sa |
Particules enrobees a gout masque, leur procede de preparation et comprimes orodispersibles contenant lesdites particules
|
|
RU2241985C1
(ru)
*
|
2003-03-27 |
2004-12-10 |
Томский политехнический университет |
Способ количественного определения азитромицина дигидрата методом инверсионной вольтамперометрии
|
|
AU2004238253B2
(en)
*
|
2003-05-06 |
2011-01-27 |
Nostrum Pharmaceuticals, Inc. |
Controlled release formulation of erythromycin derivatives
|
|
US7063862B2
(en)
|
2003-06-03 |
2006-06-20 |
Biokey, Inc. |
Pharmaceutical composition and method for treating
|
|
AU2004249211A1
(en)
*
|
2003-06-16 |
2004-12-29 |
Andrx Pharmaceuticals, Llc |
Oral extended-release composition
|
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
|
CA2533178C
(en)
|
2003-07-21 |
2014-03-11 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
|
JP2006528190A
(ja)
|
2003-07-21 |
2006-12-14 |
アドバンシス ファーマスーティカル コーポレイション |
抗生物質製剤、その使用法及び作成方法
|
|
EP1648418A4
(en)
|
2003-07-21 |
2011-11-16 |
Middlebrook Pharmaceuticals Inc |
ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
|
|
JP2005041838A
(ja)
*
|
2003-07-24 |
2005-02-17 |
Matsumoto Shika Univ |
バイオフィルム除去剤
|
|
US20050025829A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Kim Cherng-Ju |
Controlled drug release tablets
|
|
CL2004001884A1
(es)
*
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE10336400A1
(de)
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
DE10361596A1
(de)
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
AU2004264939A1
(en)
|
2003-08-11 |
2005-02-24 |
Middlebrook Pharmaceuticals, Inc. |
Robust pellet
|
|
AU2004264356B2
(en)
*
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
|
JP5686494B2
(ja)
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
|
BRPI0414082A
(pt)
*
|
2003-09-02 |
2006-10-24 |
Pfizer Prod Inc |
formas de dosagem de liberação sustentada de ziprasidona
|
|
EP1663169A4
(en)
|
2003-09-15 |
2010-11-24 |
Middlebrook Pharmaceuticals In |
ANTIBIOTICS, ITS USE AND FORMULATION
|
|
KR20060092281A
(ko)
*
|
2003-12-04 |
2006-08-22 |
화이자 프로덕츠 인크. |
액체 기초 방법에 의한 아지트로마이신 복합입자 투여형
|
|
JP2007513139A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
安定性の改善した多粒子組成物
|
|
WO2005053652A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
|
EP1689368B1
(en)
*
|
2003-12-04 |
2016-09-28 |
Bend Research, Inc |
Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
|
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
|
WO2005053654A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release dosage forms of azithromycin
|
|
EP1701702A1
(en)
*
|
2003-12-04 |
2006-09-20 |
Pfizer Products Inc. |
Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
|
|
DK1691787T3
(da)
*
|
2003-12-04 |
2008-09-22 |
Pfizer Prod Inc |
Fremgangsmåde til at danne småpartikler
|
|
US20040224019A1
(en)
*
|
2004-03-03 |
2004-11-11 |
Adi Shefer |
Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
|
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
US8007827B2
(en)
*
|
2004-04-02 |
2011-08-30 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties
|
|
US20050226927A1
(en)
*
|
2004-04-02 |
2005-10-13 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
|
|
WO2005120585A1
(en)
*
|
2004-06-04 |
2005-12-22 |
Case Western Reserve University |
Dual function polymer micelles
|
|
EP1753405A4
(en)
*
|
2004-06-10 |
2008-09-17 |
Glatt Air Tech Inc |
SLOW RELEASE PHARMACEUTICAL PREPARATION
|
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
CA2572292A1
(en)
|
2004-07-02 |
2006-02-09 |
Advancis Pharmaceutical Corporation |
Tablet for pulsed delivery
|
|
HUE028342T2
(en)
*
|
2004-10-08 |
2016-12-28 |
Forward Pharma As |
Pharmaceutical preparations containing controlled release fumaric acid ester
|
|
JP2008524317A
(ja)
*
|
2004-12-21 |
2008-07-10 |
ファイザー・プロダクツ・インク |
腸溶コーティングされたアジスロマイシン多粒子
|
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
WO2007008305A1
(en)
*
|
2005-07-08 |
2007-01-18 |
Cherng-Ju Kim |
Asymmetrically coated tablet
|
|
US8858993B2
(en)
*
|
2005-07-25 |
2014-10-14 |
Metrics, Inc. |
Coated tablet with zero-order or near zero-order release kinetics
|
|
EP1749519A1
(de)
*
|
2005-08-05 |
2007-02-07 |
Schering Aktiengesellschaft |
Arzneiform mit Retardtierter pH-unabhängiger Wirkstofffreisetzung für Wirkstoffe mit starker pH-abhängiger Löslichkeit
|
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
|
WO2007073596A1
(en)
*
|
2005-12-27 |
2007-07-05 |
Labopharm Inc. |
Degradable polymeric microsphere composition
|
|
US20090176882A1
(en)
*
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
|
US20070191271A1
(en)
*
|
2006-02-10 |
2007-08-16 |
Dow Pharmaceutical Sciences |
Method for stabilizing polypeptides lacking methionine
|
|
US20070243248A1
(en)
*
|
2006-04-14 |
2007-10-18 |
Cherukuri S Rao |
Rapidly disintegrating solid oral dosage form of liquid dispersions
|
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
|
AU2007256844A1
(en)
*
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
US7713549B2
(en)
*
|
2006-06-30 |
2010-05-11 |
Board Of Trustees Of The University Of Arkansas |
Extended release perforated tablet
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
US7910135B2
(en)
*
|
2006-10-13 |
2011-03-22 |
Uluru Inc. |
Hydrogel wound dressing and biomaterials formed in situ and their uses
|
|
US20110052688A1
(en)
*
|
2006-11-21 |
2011-03-03 |
San-Laung Chow |
Solid dispersion composition
|
|
US10357462B2
(en)
*
|
2006-11-30 |
2019-07-23 |
Ben Research, Inc. |
Multiparticulates of spray-coated drug and polymer on a meltable core
|
|
US11116728B2
(en)
|
2006-11-30 |
2021-09-14 |
Bend Research, Inc. |
Multiparticulates of spray-coated drug and polymer on a meltable core
|
|
CN100441196C
(zh)
*
|
2006-12-15 |
2008-12-10 |
北京化工大学 |
一种制备微粉化阿奇霉素的方法
|
|
CA2677076C
(en)
*
|
2007-03-02 |
2017-09-12 |
Meda Pharmaceuticals Inc. |
Compositions comprising carisoprodol and methods of use thereof
|
|
US20080228268A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Uluru, Inc. |
Method of Formation of Viscous, Shape Conforming Gels and Their Uses as Medical Prosthesis
|
|
BRPI0700969A
(pt)
*
|
2007-03-22 |
2008-11-04 |
Ouro Fino Participacoes E Empr |
composição para o tratamento de afecções bacterianas e inflamatórias em animais de companhia
|
|
US7850453B2
(en)
*
|
2007-08-08 |
2010-12-14 |
Coll Partners Ltd. |
Reshapable device for fixation at a dental site
|
|
US8124123B2
(en)
*
|
2007-09-05 |
2012-02-28 |
Dow Pharmaceutical Sciences, Inc. |
Controlled release azithromycin solid dosages forms
|
|
AU2008297905A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a laminin peptide as a therapeutic agent
|
|
AU2008297895A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of salusin beta alone or in combination with octreotide as a therapeutic agent
|
|
AU2008297411A1
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
WO2009033717A2
(en)
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of gonadorelin as a therapeutic agent
|
|
EP2185179A1
(en)
|
2007-09-11 |
2010-05-19 |
Mondobiotech Laboratories AG |
Proadrenomedullin alone or in combination with big gastrin i as a therapeutic agent
|
|
RU2010114036A
(ru)
|
2007-09-11 |
2011-10-20 |
Мондобайотек Лабораториз Аг (Li) |
ПРИМЕНЕНИЕ ПЕПТИДА His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe ИНДИВИДУАЛЬНО ИЛИ В СОЧЕТАНИИ С ПЕПТИДОМ Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys-OH В КАЧЕСТВЕ ТЕРАПЕВТИЧЕСКОГО СРЕДСТВА
|
|
RU2010114026A
(ru)
|
2007-09-11 |
2011-10-20 |
Мондобайотек Лабораториз Аг (Li) |
Применение глютенэкзорфина с в качестве терапевтического средства
|
|
CA2699075A1
(en)
|
2007-09-11 |
2009-04-23 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
KR20100057051A
(ko)
|
2007-09-11 |
2010-05-28 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 옥트레오티드의 용도
|
|
BRPI0906467C1
(pt)
|
2008-01-25 |
2021-05-25 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica com formato exterior modificado resistente à ruptura e com liberação controlada
|
|
DE102008022520A1
(de)
*
|
2008-05-07 |
2009-11-12 |
Bayer Animal Health Gmbh |
Feste Arzneimittelformulierung mit verzögerter Freisetzung
|
|
PT2273983T
(pt)
|
2008-05-09 |
2016-10-28 |
Gruenenthal Gmbh |
Processo para a preparação de uma formulação em pó intermediária e uma forma de dosagem sólida final sob utilização de uma etapa de congelamento por atomização
|
|
TWI478712B
(zh)
|
2008-09-30 |
2015-04-01 |
Astellas Pharma Inc |
釋控性醫藥組成物
|
|
EP2198859A1
(en)
*
|
2008-12-17 |
2010-06-23 |
Losan Pharma GmbH |
Melt-coated pharmaceutical composition with fast release
|
|
MX2012000317A
(es)
|
2009-07-22 |
2012-02-08 |
Gruenenthal Gmbh |
Forma de dosificacion de liberacion controlada extruida por fusion en caliente.
|
|
WO2011009604A1
(en)
|
2009-07-22 |
2011-01-27 |
Grünenthal GmbH |
Oxidation-stabilized tamper-resistant dosage form
|
|
NZ599524A
(en)
|
2009-11-09 |
2014-04-30 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
|
EP2498764B1
(en)
|
2009-11-09 |
2017-09-06 |
Spotlight Technology Partners LLC |
Fragmented hydrogels
|
|
EP2547322A2
(en)
|
2010-03-15 |
2013-01-23 |
Ulrich Dietz |
Use of nitrocarboxylic acids for the treatment, diagnosis and prophylaxis of aggressive healing patterns
|
|
WO2011125075A2
(en)
|
2010-04-08 |
2011-10-13 |
Fdc Limited |
A novel gastroretentive delivery of macrolide
|
|
CA2808219C
(en)
|
2010-09-02 |
2019-05-14 |
Gruenenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
|
CN103179954A
(zh)
|
2010-09-02 |
2013-06-26 |
格吕伦塔尔有限公司 |
包含阴离子聚合物的抗破碎剂型
|
|
TW201309346A
(zh)
|
2011-01-05 |
2013-03-01 |
Hospira Inc |
噴霧乾燥萬古黴素
|
|
HUE034711T2
(en)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Anti-Abuse, Immediate Release Tablet
|
|
DK2736497T3
(da)
|
2011-07-29 |
2017-11-13 |
Gruenenthal Gmbh |
Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
|
|
KR101953413B1
(ko)
*
|
2011-08-08 |
2019-02-28 |
앨러간 파마슈티컬스 인터내셔널 리미티드 |
소화효소들을 함유하는 고형 조성물들의 용해 시험 방법
|
|
CA2885680C
(en)
*
|
2011-09-07 |
2022-10-04 |
Roland Saur-Brosch |
Formulation for the controlled release of one or several substances in the digestive tract of a mammal.
|
|
US10653631B2
(en)
|
2011-09-07 |
2020-05-19 |
Roland SAUR-BROSCH |
Optimal colon targeting technology
|
|
US20130143867A1
(en)
|
2011-12-02 |
2013-06-06 |
Sychroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
|
US20130172271A1
(en)
*
|
2012-01-04 |
2013-07-04 |
Cynthia Fragale |
Pharmaceutical Spray Drying
|
|
AU2013225106B2
(en)
|
2012-02-28 |
2017-11-02 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
|
AR090695A1
(es)
|
2012-04-18 |
2014-12-03 |
Gruenenthal Gmbh |
Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
RU2498805C1
(ru)
*
|
2012-07-23 |
2013-11-20 |
Открытое акционерное общество "Биосинтез" |
Твердая лекарственная форма азитромицина
|
|
US20150202161A1
(en)
*
|
2012-08-20 |
2015-07-23 |
O-Ray Pharma, Inc. |
Process for manufacturing drug delivery formulations
|
|
CN103860515A
(zh)
*
|
2012-12-10 |
2014-06-18 |
中国科学院上海药物研究所 |
阿奇霉素渗透泵控释片及其制备方法
|
|
CN104043104B
(zh)
|
2013-03-15 |
2018-07-10 |
浙江创新生物有限公司 |
含盐酸万古霉素的喷雾干粉及其工业化制备方法
|
|
JP6041823B2
(ja)
|
2013-03-16 |
2016-12-14 |
ファイザー・インク |
トファシチニブの経口持続放出剤形
|
|
CN104177457A
(zh)
*
|
2013-05-23 |
2014-12-03 |
长春海悦药业有限公司 |
一种阿奇霉素药物原料及其制剂和用途
|
|
US9737490B2
(en)
|
2013-05-29 |
2017-08-22 |
Grünenthal GmbH |
Tamper resistant dosage form with bimodal release profile
|
|
JP6445537B2
(ja)
|
2013-05-29 |
2018-12-26 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
1個または複数の粒子を含有する改変防止(tamper−resistant)剤形
|
|
EP3003297A4
(en)
|
2013-06-05 |
2017-04-19 |
Synchroneuron Inc. |
Acamprosate formulations, methods of using the same, and combinations comprising the same
|
|
MX368846B
(es)
|
2013-07-12 |
2019-10-18 |
Gruenenthal Gmbh |
Forma de dosificación resistente a la alteración que contiene polímero de acetato de etilen-vinilo.
|
|
US9668844B2
(en)
|
2013-11-06 |
2017-06-06 |
Colldent Y.A Ltd |
Device for fixation at a dental site
|
|
CA2931553C
(en)
|
2013-11-26 |
2022-01-18 |
Grunenthal Gmbh |
Preparation of a powdery pharmaceutical composition by means of cryo-milling
|
|
CA2947786A1
(en)
|
2014-05-12 |
2015-11-19 |
Grunenthal Gmbh |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
|
CA2949422A1
(en)
|
2014-05-26 |
2015-12-03 |
Grunenthal Gmbh |
Multiparticles safeguarded against ethanolic dose-dumping
|
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
|
CA2988575C
(en)
*
|
2015-06-10 |
2024-04-16 |
Piedmont Animal Health, Llc |
Injectable antibiotic formulations and use thereof
|
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
WO2018190621A1
(ko)
*
|
2017-04-10 |
2018-10-18 |
성균관대학교 산학협력단 |
다공성 위체류층을 포함하는 서방성 제제 및 이의 제조방법
|
|
GB201904757D0
(en)
*
|
2019-04-04 |
2019-05-22 |
Biorelevant Com Ltd |
Biorelevant composition
|
|
CN114585380A
(zh)
|
2019-10-11 |
2022-06-03 |
安纳塔拉生命科学有限公司 |
胃肠健康组合物
|
|
CN112326838A
(zh)
*
|
2020-11-10 |
2021-02-05 |
湖北省宏源药业科技股份有限公司 |
一种改善阿奇霉素胶囊溶出曲线的测定方法
|
|
CN113116859B
(zh)
*
|
2021-04-12 |
2022-08-30 |
海南普利制药股份有限公司 |
阿奇霉素丸芯包衣制剂
|
|
CN113985783B
(zh)
*
|
2021-10-29 |
2022-09-02 |
中山东菱威力电器有限公司 |
一种冰激淋料浆有无检测电路
|
|
US12097189B1
(en)
|
2024-02-09 |
2024-09-24 |
Astellas Pharma Inc. |
Pharmaceutical composition for modified release
|